latest news releases from the newsroom
SeaDrill Ltd -- Mandatory Notification of Trade
HAMILTON, Norway, Jan. 23, 2006 (PRIMEZONE) -- Hemen Holding Ltd., a company indirectly controlled by John Fredriksen, has on 22 January 2006 been allocated 25,000,000 shares in a private placement in SeaDrill at a price per share of NOK 66. Following this transaction, Hemen Holding Ltd. including affiliated companies, owns a total of 124,441,916 shares in SeaDrill, constituting 40.9% of the company's issued share capital.
SeaDrill Ltd -- Disclosure of Share Acquisition in Smedvig ASA ('Smedvig')
HAMILTON, Norway, Jan. 23, 2006 (PRIMEZONE) -- Reference is made to the press release dated 21 January 2006 regarding the acceptance level in the voluntary offer of Smedvig. After the expiry of the Offer Period, SeaDrill has received acceptances for a total of 24,876,009 class A-shares and 15,417,402 class B-shares. Including both the accepted shares and the already owned shares, SeaDrill controls a total of 27,546,609 class A-shares and 15,417,402 class B-shares, constituting 51.24% of the Smedvig votes and 52.57% of the Smedvig capital.
AMOI Selects Bitfone's Device Management and FOTA Technologies
LAGUNA NIGUEL, Calif., Jan. 23, 2006 (PRIMEZONE) -- Bitfone Corporation (www.bitfone.com), the pioneer and patentholder of firmware over-the-air (FOTA) update technology for mobile phones, today announced that Amoi Electronics, one of the largest Chinese mobile phone manufacturers, has selected Bitfone's comprehensive device management client suite to fulfill their requirements for Open Mobile Alliance Device Management (OMA DM) industry standard, FOTA, and remote diagnostics support for their mobile devices.
Aventura Holdings, Inc.
Aventura Holdings, Inc. Releases March 31, 2005 10-Q/A
MIAMI, Jan. 20, 2006 (PRIMEZONE) -- In an effort to amend certain presentations and disclosures in the Company's previously filed March 31, 2005 quarterly report, Aventura Holdings, Inc. (OTCBB:AVNT) (Frankfurt: WKN#570891) ("Aventura") filed an amended March 31, 2005 quarterly report (Form 10-Q/A). The amended filing clarifies presentation deficiencies the SEC cited in a comment letter dated July 8, 2005.
Port of Houston Authority
PHA Commission Considers Bayport, Security, Capital Improvement Matters and Partnership Service Agreement
HOUSTON, Jan. 20, 2006 (PRIMEZONE) -- The Port of Houston Authority (PHA) commission will consider several recommendations involving contract awards, bids and proposals, professional services and general administrative and operational matters during its public meeting at 2 p.m. on Monday, January 23, 2006 in the board room at the PHA Executive Building, 111 East Loop North (Exit 29 off Loop 610) in Houston. Chairman Jim Edmonds will preside over the meeting with Commissioner Kase Lawal, Commissioner Steve Phelps, Commissioner Jim Fonteno, Commissioner Jimmy Burke, Commissioner Cheryl Thompson-Draper, and Commissioner Janiece Longoria.
EarthShell Corporation Board Chairman Resigns
SANTA BARBARA, Calif., Jan. 20, 2006 (PRIMEZONE) -- EarthShell(r) Corporation (OTCBB:ERTH) announced today that one of its directors, Simon K. Hodson, has resigned as a director of EarthShell, effective immediately. Mr. Hodson has also been serving as chairman of the Board. Mr. Hodson has resigned in order to focus his efforts on his recent appointment as Chief Executive Officer of E.Khashoggi Industries, LLC (EKI). EKI is EarthShell Corporation's ("EarthShell") largest stockholder. EarthShell holds an exclusive license on a worldwide basis from EKI to commercialize patented material technology for the manufacture of foodservice disposable packaging. A new chairman of the Board will be elected at the next regularly scheduled meeting of EarthShell's Board of Directors and the corporate governance committee of the Board will initiate a search for a new director to fill the vacancy on the Board.
Diamyd Medical AB
Interim Report for Diamyd Medical AB
STOCKHOLM, Sweden, Jan. 20, 2006 (PRIMEZONE) -- Diamyd Medical AB (Pink Sheets:DMYDF), a global biotechnology company focused on the treatment of diabetes and its complications, including chronic pain and neuropathy, today announced its financial results for the period ended November 30, 2005.